Jové M (1), Ayala V (1), Ramírez-Núñez O (1), Serrano JC (1), Cassanyé A (1), Arola L (2,3), Caimari A (3), Del Bas JM (3), Crescenti A (3), Pamplona R (1), Portero-Otín M (1)
(1) Department of Experimental Medicine, Faculty of Medicine, Universitat de Lleida-IRBLleida, 25198 Lleida, Spain.
(2) Nutrigenomics Research Group, Departament de Bioquímica i Biotecnologia, Universitat Rovira i Virgili, Tarragona, Spain.
(3) Centre Tecnològic de Nutrició i Salut (CTNS), TECNIO, CEICS, Reus, Spain.
AIMS: Atherosclerosis is the main pathological process contributing to cardiovascular disease, with diet being the most important factor involved. Although the lipidome of atheromatous plaque has been studied previously, the use of comparative lipidomics and metabolomics in plasma in early atherogenesis could lead to the discovery of plasma biomarkers that allow not only disease prediction but also measurement of disease progression.
METHODS AND RESULTS: High-throughput techniques, such as liquid chromatography/mass spectrometry, allowed us to compare the circulating and aortic lipidome and plasma metabolome in order to look for new molecular targets involved in atherogenesis. To achieve this objective, we chose the hamster (Mesocricetus auratus) as the best small animal model for diet-induced early atherosclerosis, because its lipoprotein metabolism is similar to that of humans. The results revealed the existence of several, previously unreported, changes in lipid and amino-acid metabolism, the peroxisome proliferator-activated receptor γ pathway, and oxidative and endoplasmic reticulum stress, also involving cell senescence. Furthermore, as a proof of concept in the modelling of dietary influences in atherogenesis, we have measured the effect of a potential anti-atherogenic polyphenol extract on the reported pathways. Our results support a previously unknown role for taurocholic acid as a potential plasma biomarker of early atheromatous plaque formation.
CONCLUSION: The use of comparative liquid chromatography/mass spectrometry-based lipidomics and metabolomics allows the discovery of novel pathways in atherogenesis, as well as new potential plasma biomarkers, which could allow us to predict disease in its early stages and measure its progression.
Event date: 12/12/2012
Publication date: Wed Apr 30 18:23:00 CEST 2014